abstract |
The present invention relates to the use of a quinazolinone compound of the formula (I) (see formula I) wherein R1, R2, R3, R4, R5 and m are as defined in the specification, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid antagonist. |